California lawmakers set aside $100 million in the recently adopted 2022-23 state budget to help launch the CalRx drug label, and the state could start producing generic insulin within the next few years.
The pharmaceutical industry, notorious for its deep pockets and aggressive lobbying tactics, has a nearly spotless record dominating policy fights. Now, the sector is staring down its biggest test in at least a decade.
Teva Pharmaceutical Industries on Tuesday announced a $4.35 billion proposed nationwide settlement that could resolve thousands of lawsuits over the drugmaker's alleged role in the US opioid epidemic.
President Biden has begun taking a course of Paxlovid, after testing positive for COVID-19. The antiviral medicine is recommended for early treatment by the CDC.